Overview
In response to the continuing COVID-19 crisis, regulatory authorities have focused on providing support for the rapid development of vaccines and treatments and the expedited approval and implementation of agile regulatory systems.
The NIFDS-DIA Workshop 2021 will explore the theme of “Facilitating the Development and Regulations of COVID-19 Vaccines and Treatments / Current Trends in New Drug Developments and Regulations.”
Featured
Want to learn more about NiFDS-DIA Workshop 2021: Facilitating the Development and Regulations of Covid-19 Vaccines and Treatments / Current Trends in New Drug Development and Regulations? You've come to the right site!
Program Committee
-
Hae-Young Ahn, PhD President
Ahn Bio, United States -
So Hee Kim, PhD Director / Pharmacist, Ministry of Food and Drug Safety
National Institute of Food and Drug Safety Evaluation (NIFDS), Korea, Republic of -
Younglim Kim, PhD Director General
National Institute of Food & Drug Safety (NIFDS), Korea, Republic of -
Jeewon Jeong, PhD Director
Korean Ministry of Food and Drug Safety (MFDS) , Korea, Republic of -
Junesik Mune, MD, PhD VP, Clinical & Regulatory Affairs Center
LG Chem, Korea, Republic of -
Rok Song Research Scientist
IVI, Korea, Republic of -
Kyung Won Seo Director General, National Institute of Food and Drug Safety Evaluation
Ministiry of Food and Drug Safety, Korea, Republic of -
Younjoo Park Director, General of Department
MFDS, Korea, Republic of -
In-sook Park Director General
Korean Regulatory Science Center, Korea, Republic of
Have an account?